Xenon Pharmaceuticals Inc.

XENE

—

Advanced chart & tools →

Xenon Pharmaceuticals Inc.XENE

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-4.36

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$7.50M

Net income

$-345.91M

Net margin

-4612.1%

Gross margin

—

Dividends & financials

Xenon Pharmaceuticals Inc. (XENE) reported revenue of $7.50M and net income of $-345.91M, or $-4.36 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.